These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms. Carratt SA; Kong GL; Curtiss BM; Schonrock Z; Maloney L; Maniaci BN; Blaylock HZ; Baris A; Druker BJ; Braun TP; Maxson JE Blood; 2022 Aug; 140(6):644-658. PubMed ID: 35482940 [TBL] [Abstract][Full Text] [Related]
23. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy. Elliott MA; Tefferi A Curr Opin Hematol; 2014 Mar; 21(2):148-54. PubMed ID: 24335708 [TBL] [Abstract][Full Text] [Related]
24. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management. Elliott MA; Tefferi A Am J Hematol; 2018 Aug; 93(4):578-587. PubMed ID: 29512199 [TBL] [Abstract][Full Text] [Related]
25. Chronic neutrophilic leukemia preceded by myelodysplastic syndromes. Baba Y; Nakamaki T; Sakai H; Fukuchi K; Kabasawa N; Hattori N; Harada H Int J Hematol; 2023 Nov; 118(5):636-641. PubMed ID: 37439996 [TBL] [Abstract][Full Text] [Related]
26. Current strategies in the diagnosis and management of chronic neutrophilic leukemia. Otgonbat A; Zhao M Chin Med J (Engl); 2014; 127(24):4258-62. PubMed ID: 25533830 [TBL] [Abstract][Full Text] [Related]
27. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management. Szuber N; Elliott M; Tefferi A Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070 [TBL] [Abstract][Full Text] [Related]
28. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes. Carreño-Tarragona G; Álvarez-Larrán A; Harrison C; Martínez-Ávila JC; Hernández-Boluda JC; Ferrer-Marín F; Radia DH; Mora E; Francis S; González-Martínez T; Goddard K; Pérez-Encinas M; Narayanan S; Raya JM; Singh V; Gutiérrez X; Toth P; Amat-Martínez P; Mcilwaine L; Alobaidi M; Mayani K; McGregor A; Stuckey R; Psaila B; Segura A; Alvares C; Davidson K; Osorio S; Cutting R; Sweeney CP; Rufián L; Moreno L; Cuenca I; Smith J; Morales ML; Gil-Manso R; Koutsavlis I; Wang L; Mead AJ; Rozman M; Martínez-López J; Ayala R; Cross NCP Blood Adv; 2023 May; 7(9):1672-1681. PubMed ID: 36375042 [TBL] [Abstract][Full Text] [Related]
29. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management. Szuber N; Elliott M; Tefferi A Am J Hematol; 2022 Apr; 97(4):491-505. PubMed ID: 35089603 [TBL] [Abstract][Full Text] [Related]
30. Clonal evolution in a chronic neutrophilic leukemia patient. Zhang QG; Wang J; Gong WY; Jing QC Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019 [TBL] [Abstract][Full Text] [Related]
31. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms. Tefferi A; Thiele J; Vannucchi AM; Barbui T Leukemia; 2014 Jul; 28(7):1407-13. PubMed ID: 24441292 [TBL] [Abstract][Full Text] [Related]
32. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications. Mitsumori T; Komatsu N; Kirito K Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968 [TBL] [Abstract][Full Text] [Related]
33. Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management. Elliott MA; Tefferi A Am J Hematol; 2016 Mar; 91(3):341-9. PubMed ID: 26700908 [TBL] [Abstract][Full Text] [Related]
34. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature. Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413 [TBL] [Abstract][Full Text] [Related]
35. Chronic neutrophilic leukemia: new science and new diagnostic criteria. Szuber N; Tefferi A Blood Cancer J; 2018 Feb; 8(2):19. PubMed ID: 29440636 [TBL] [Abstract][Full Text] [Related]
36. Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis. Langabeer SE; Haslam K; Kelly J; Quinn J; Morrell R; Conneally E Clin Transl Oncol; 2018 Mar; 20(3):420-423. PubMed ID: 28762112 [TBL] [Abstract][Full Text] [Related]
37. [Chronic neutrophilic leukemia complicated with multiple myeloma: two cases report and literature review]. Jiang B; Qi JY; Li QH; Xu Y; Sun MY; Zheng WW; Chen F; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):688-91. PubMed ID: 27587251 [TBL] [Abstract][Full Text] [Related]
38. [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia]. Cui YJ; Jiang Q; Liu JQ; Li B; Xu ZF; Qin TJ; Zhang Y; Cai WY; Zhang HL; Fang LW; Pan LJ; Hu NB; Qu SQ; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):28-32. PubMed ID: 28219221 [No Abstract] [Full Text] [Related]
39. [Analysis of Clinical Features and Prognosis of Patients with Chronic Neutrophil Leukemia]. Guo YJ; Wang Y; Wang LH; Zuo YB; Niu ZY; Lin FR; Zhang JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):82-87. PubMed ID: 32027257 [TBL] [Abstract][Full Text] [Related]
40. Current Management of Chronic Neutrophilic Leukemia. Szuber N; Tefferi A Curr Treat Options Oncol; 2021 Jun; 22(7):59. PubMed ID: 34097138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]